Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing Study of Onglyza (saxagliptin) in Type 2 Diabetes Mellitus
jRCT1080222299Phase 4
- Sponsor
- Kyowa Kirin
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Onglyza with Placebo (2 arms).
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1080222299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222299.